Members' News

21 Jul 2017

Cyclacel Announces Closing of $15.2 Million

Cyclacel Announces Closing of $15.2 Million Underwritten Public Offering and Full Exercise of Over-Allotment Option BERKELEY HEIGHTS, N.J., July 21, 2017 (GLOBE NEWSWIRE) --

7 Jul 2017

Collagen Solutions Announces First Patient Enrolment in ChondroMimetic Clinical Study

Collagen Solutions plc (AIM: COS), the developer and manufacturer of medical grade collagen components for use in regenerative medicine, medical devices and in-vitro diagnostics, announces the commencement of patient en…

3 Jul 2017

Ryboquin Secures 1.8m Equity Funding

Ryboquin Secures £1.8m Equity Funding

22 Jun 2017

Sistemic Ltd Announce Innovate UK Grant to Develop Grounbreaking miRNA-based Assay

Sistemic awarded an Innovate UK grant to develop a groundbreaking, novel miRNA-based assay for accurate assessment of pluripotent stem cell contamination in derived cell therapy products Glasgow, Scotland, 22th June 20…

13 Jun 2017

Collagen Solutions - Provisional Patent for Bone Graft Substitute Formulation Submitted

8 May 2017

Lamellar Biomedical Raises 5.75m in Series C Fund Raising Led by Invesco

Lamellar Biomedical Raises £5.75 million in Series C Fund Raising Led by Invesco

4 May 2017

Sartorius Stedim Biotech Launches Chemistry Testing Services

28 Apr 2017

SBRI Funding Competition: Clinical Decision Support In Emergency Care

SBRI funding competition: clinical decision support in emergency care From:Innovate UKPart of:Innovation grants for business: apply for funding, Business enterprise, and Research and innovation in healt…

27 Apr 2017

Dundee Cell Products Ltd. Rebrands as DC BIOSCIENCES Ltd

Please click here for the full press release

25 Apr 2017

Medical Research Scotland PhD Studentships - Call Open

MEDICAL RESEARCH SCOTLAND

19 Apr 2017

Synpromics Raises 5.2m of New Investment

Edinburgh, UK, 19th April 2017 / Synpromics Ltd, the leading synthetic promoter and gene control company, is pleased to announce that it has completed a financing round of £5.2M.

6 Apr 2017

MGB Biopharma Closes $1 million Financing Round to Finance Manufacturing of MGB-BP-3

 MGB Biopharma Closes $1 million Financing Round to Finance Manufacturing of MGB-BP-3 for Phase II Study in Clostridium difficile-Associated Disease (CDAD)

23 Mar 2017

Opportunity to Hear David Evans Present 'A Chairman's Story' at UK Investor Show

 23 March 2017

14 Mar 2017

Mirador Analytics Launches Online Version of Asset Evaluation Tool

Revolutionizing Asset Evaluation for Drug Development and Commercialization

22 Feb 2017

Aridhia Wins 10-Year Deal with Great Ormond Street Hospital

Click here for full Press Release